Resolvin E2: Identification and Anti-Inflammatory Actions: Pivotal Role of Human 5-Lipoxygenase in Resolvin E Series Biosynthesis
- 27 November 2006
- journal article
- Published by Elsevier
- Vol. 13 (11) , 1193-1202
- https://doi.org/10.1016/j.chembiol.2006.09.011
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Biological basis for the cardiovascular consequences of COX-2 inhibition: therapeutic challenges and opportunitiesJournal of Clinical Investigation, 2005
- Host control of Mycobacterium tuberculosis is regulated by 5-lipoxygenase–dependent lipoxin productionJournal of Clinical Investigation, 2005
- Stereochemical assignment, antiinflammatory properties, and receptor for the omega-3 lipid mediator resolvin E1The Journal of Experimental Medicine, 2005
- Novel ? ? 3-derived local mediators in anti-inflammation and resolutionPharmacology & Therapeutics, 2005
- Defective lipoxin-mediated anti-inflammatory activity in the cystic fibrosis airwayNature Immunology, 2004
- Points of control in inflammationNature, 2002
- ResolvinsThe Journal of Experimental Medicine, 2002
- Anti-inflammatory lipid mediators and insights into the resolution of inflammationNature Reviews Immunology, 2002
- Lipoxin biosynthesis and its impact in inflammatory and vascular eventsBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1994
- Lipoxin generation by permeabilized human plateletsBiochemistry, 1992